Resources

Case Study: An siRNA Drug Product IND Filing Ready in 10 Months

Small interfering RNA therapeutics are advanced oligonucleotide therapy. WuXi STA oligonucleotide CRDMO platform provides the integrated solution for siRNA candidates.

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes